124 related articles for article (PubMed ID: 36791055)
21. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
22. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
[TBL] [Abstract][Full Text] [Related]
23. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
[TBL] [Abstract][Full Text] [Related]
24. MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.
Griffin AC; Kern MJ; Kirkwood KL
Mol Endocrinol; 2012 Oct; 26(10):1682-93. PubMed ID: 22899855
[TBL] [Abstract][Full Text] [Related]
25. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
27. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
28. 1,25-dihydroxyvitamin D3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of p38 mitogen-activated protein kinase.
Yamamoto T; Kozawa O; Tanabe K; Akamatsu S; Matsuno H; Dohi S; Hirose H; Uematsu T
Arch Biochem Biophys; 2002 Feb; 398(1):1-6. PubMed ID: 11811942
[TBL] [Abstract][Full Text] [Related]
29. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis.
Yang R; Chen J; Zhang J; Qin R; Wang R; Qiu Y; Mao Z; Goltzman D; Miao D
Aging Cell; 2020 Feb; 19(2):e13095. PubMed ID: 31880094
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D endocrinology of bone mineralization.
van Driel M; van Leeuwen JPTM
Mol Cell Endocrinol; 2017 Sep; 453():46-51. PubMed ID: 28606868
[TBL] [Abstract][Full Text] [Related]
31. Enhanced insulin activity achieved in VDRa/b ablation zebrafish.
Liu R; Lu Y; Peng X; Jia J; Ruan Y; Shi S; Shu T; Li T; Jin X; Zhai G; He J; Lou Q; Yin Z
Front Endocrinol (Lausanne); 2023; 14():1054665. PubMed ID: 36864841
[TBL] [Abstract][Full Text] [Related]
32. Inducible expression of p57KIP2 inhibits glioma cell motility and invasion.
Sakai K; Peraud A; Mainprize T; Nakayama J; Tsugu A; Hongo K; Kobayashi S; Rutka JT
J Neurooncol; 2004 Jul; 68(3):217-23. PubMed ID: 15332324
[TBL] [Abstract][Full Text] [Related]
33. Role of p57KIP2 in Stem and Progenitor Leydig Cells of Mouse Testes.
Park SH; Yoon KN; Xu Y; Gye MC
World J Mens Health; 2024 Apr; ():. PubMed ID: 38772531
[TBL] [Abstract][Full Text] [Related]
34. [Expression of p57kip2 in patients with de novo myelodysplastic syndrome and its relationship with SDF-1/CXCR4 axis].
Zhao YS; Guo J; Yang R; Gu SC; Zhang X; Zhou LY; Li X; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):352-7. PubMed ID: 22541097
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.
Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y
Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957
[TBL] [Abstract][Full Text] [Related]
36. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
37. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.
Heinen A; Kremer D; Göttle P; Kruse F; Hasse B; Lehmann H; Hartung HP; Küry P
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8748-53. PubMed ID: 18550808
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
39. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2.
Cesario JM; Landin Malt A; Deacon LJ; Sandberg M; Vogt D; Tang Z; Zhao Y; Brown S; Rubenstein JL; Jeong J
Hum Mol Genet; 2015 Sep; 24(17):5024-39. PubMed ID: 26071365
[TBL] [Abstract][Full Text] [Related]
40. Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro.
Sooy K; Sabbagh Y; Demay MB
J Cell Biochem; 2005 Jan; 94(1):81-7. PubMed ID: 15517598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
